220 related articles for article (PubMed ID: 29155421)
1. Characterization of neural stem cells modified with hypoxia/neuron-specific VEGF expression system for spinal cord injury.
Yun Y; Oh J; Kim Y; Kim G; Lee M; Ha Y
Gene Ther; 2018 Jan; 25(1):27-38. PubMed ID: 29155421
[TBL] [Abstract][Full Text] [Related]
2. A Gene and Neural Stem Cell Therapy Platform Based on Neuronal Cell Type-Inducible Gene Overexpression.
Oh J; You Y; Yun Y; Lee HL; Yoon DH; Lee M; Ha Y
Yonsei Med J; 2015 Jul; 56(4):1036-43. PubMed ID: 26069128
[TBL] [Abstract][Full Text] [Related]
3. Neural stem cells modified by a hypoxia-inducible VEGF gene expression system improve cell viability under hypoxic conditions and spinal cord injury.
Lian Jin H; Pennant WA; Hyung Lee M; Su S; Ah Kim H; Lu Liu M; Soo Oh J; Cho J; Nyun Kim K; Heum Yoon D; Ha Y
Spine (Phila Pa 1976); 2011 May; 36(11):857-64. PubMed ID: 21192293
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-specific, VEGF-expressing neural stem cell therapy for safe and effective treatment of neuropathic pain.
Lee HL; Lee HY; Yun Y; Oh J; Che L; Lee M; Ha Y
J Control Release; 2016 Mar; 226():21-34. PubMed ID: 26826306
[TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic Effect of Highly Secreted GMCSF From Neuronal Cell-specific GMCSF Overexpressing Neural Stem Cells in Spinal Cord Injury Model.
You Y; Che L; Lee HY; Lee HL; Yun Y; Lee M; Oh J; Ha Y
Spine (Phila Pa 1976); 2015 Dec; 40(24):E1284-91. PubMed ID: 26230539
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury.
Kim HJ; Oh JS; An SS; Pennant WA; Gwak SJ; Kim AN; Han PK; Yoon DH; Kim KN; Ha Y
Gene Ther; 2012 May; 19(5):513-21. PubMed ID: 22011644
[TBL] [Abstract][Full Text] [Related]
8. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
9. Combined Method of Neuronal Cell-Inducible Vector and Valproic Acid for Enhanced Gene Expression under Hypoxic Conditions.
Yun Y; Baek D; Lee D; Cheong E; Kim J; Oh J; Ha Y
Tissue Eng Regen Med; 2020 Feb; 17(1):55-66. PubMed ID: 32002843
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-specific VEGF-expressing neural stem cells in spinal cord injury model.
Oh JS; An SS; Gwak SJ; Pennant WA; Kim KN; Yoon DH; Ha Y
Neuroreport; 2012 Feb; 23(3):174-8. PubMed ID: 22186804
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
[TBL] [Abstract][Full Text] [Related]
12. Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia-inducible gene expression system.
Liu ML; Oh JS; An SS; Pennant WA; Kim HJ; Gwak SJ; Yoon DH; Kim KN; Lee M; Ha Y
J Gene Med; 2010 Dec; 12(12):990-1001. PubMed ID: 21157823
[TBL] [Abstract][Full Text] [Related]
13. Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy.
Jin H; Liu ML; Kim HA; Lee M; An S; Oh J; Cho J; Yi S; Kim K; Yoon D; Ha Y
Spine (Phila Pa 1976); 2009 Dec; 34(26):E952-8. PubMed ID: 20010384
[TBL] [Abstract][Full Text] [Related]
14. AAV2-mediated and hypoxia response element-directed expression of bFGF in neural stem cells showed therapeutic effects on spinal cord injury in rats.
Zhu S; Ying Y; Ye J; Chen M; Wu Q; Dou H; Ni W; Xu H; Xu J
Cell Death Dis; 2021 Mar; 12(3):274. PubMed ID: 33723238
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor activates neural stem cells through epidermal growth factor receptor signal after spinal cord injury.
Liu SM; Xiao ZF; Li X; Zhao YN; Wu XM; Han J; Chen B; Li JY; Fan CX; Xu B; Xue XY; Xue WW; Yang Y; Dai JW
CNS Neurosci Ther; 2019 Mar; 25(3):375-385. PubMed ID: 30155986
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin signaling increases neurogenesis and oligodendrogenesis of endogenous neural stem cells following spinal cord injury both in vivo and in vitro.
Zhang H; Fang X; Huang D; Luo Q; Zheng M; Wang K; Cao L; Yin Z
Mol Med Rep; 2018 Jan; 17(1):264-272. PubMed ID: 29115443
[TBL] [Abstract][Full Text] [Related]
17. The repair and autophagy mechanisms of hypoxia-regulated bFGF-modified primary embryonic neural stem cells in spinal cord injury.
Zhu S; Chen M; Deng L; Zhang J; Ni W; Wang X; Yao F; Li X; Xu H; Xu J; Xiao J
Stem Cells Transl Med; 2020 May; 9(5):603-619. PubMed ID: 32027101
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.
Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW
Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944
[TBL] [Abstract][Full Text] [Related]
19. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
Kim HA; Park JH; Yi N; Lee M
Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of Recombinant Vascular Endothelial Growth Factor (VEGF)189-Neural Stem Cells Downregulates Transient Receptor Potential Vanilloid 1 (TRPV1) and Improves Motor Outcome in Spinal Cord Injury.
Zeng Y; Han H; Tang B; Chen J; Mao D; Xiong M
Med Sci Monit; 2018 Feb; 24():1089-1096. PubMed ID: 29466323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
